Pro12Ala and His447His polymorphisms of PPAR-γ are associated with polycystic ovary syndrome

被引:20
作者
Gu, Bon-Hee [1 ]
Baek, Kwang-Hyun [1 ]
机构
[1] CHA Univ, Grad Sch Life Sci & Biotechnol, Fertil Med Ctr, CHA Gen Hosp, Seoul 135081, South Korea
关键词
granulosa cell; insulin resistance; peroxisome proliferator-activated receptor-gamma; type; 2; diabetes; ACTIVATED-RECEPTOR-GAMMA; INSULIN-RESISTANCE; GENETIC-POLYMORPHISM; ANDROGEN EXCESS; CHINESE WOMEN; CYP1A1;
D O I
10.1016/S1472-6483(10)60008-9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects 4-12% of women of reproductive age, and is specified when two of the three following criteria are present: hyperandrogenism, oligomenorrhoea and polycystic ovary morphology by ultrasonography. PCOS is characterized by infertility, obesity and hyperinsulinaemia. However, the aetiology of PCOS has not yet been fully identified due to complex metabolic mechanisms. Many researchers have demonstrated that polymorphisms of putative genes related to symptoms are associated with PCOS. In the reproductive system, energy metabolism and hormonal regulation are important to differentiate granulosa cells in the ovary. Peroxisome proliferator-activated receptor gamma (PPAR-gamma) is a transcription factor,and is known to be associated with insulin sensitivity. Furthermore, it is highly expressed in granulosa cells. It was recently reported that various polymorphisms of PPAR-gamma are associated with PCOS in different ethnic backgrounds. This study has shown that both Pro 12Ala and His447His polymorphisms of PPAR-gamma are associated with PCOS in a Korean population.
引用
收藏
页码:644 / 650
页数:7
相关论文
共 41 条
  • [1] Abbott David H., 2008, V13, P145, DOI 10.1159/000134831
  • [2] Rolycystic ovary syndrome in the Indian subcontinent
    Aahbadia, Gautarn N.
    Merchant, Rubina
    [J]. SEMINARS IN REPRODUCTIVE MEDICINE, 2008, 26 (01) : 22 - 34
  • [3] Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome
    Antoine, Heath J.
    Pall, Marita
    Trader, Belynda C.
    Chen, Yii-Der I.
    Azziz, Ricardo
    Goodarzi, Mark O.
    [J]. FERTILITY AND STERILITY, 2007, 87 (04) : 862 - 869
  • [4] Babu KA, 2004, REPROD BIOMED ONLINE, V9, P194
  • [5] Genetics of polycystic ovarian syndrome
    Calogero, AE
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2005, 10 (06) : 713 - 720
  • [6] Carmina E, 2006, Minerva Ginecol, V58, P109
  • [7] Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism
    Carmina, E
    Rosato, F
    Jannì, A
    Rizzo, M
    Longo, RA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) : 2 - 6
  • [8] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
    Chang, J
    Azziz, R
    Legro, R
    Dewailly, D
    Franks, S
    Tarlatzis, BC
    Fauser, B
    Balen, A
    Bouchard, P
    Dahlgren, E
    Devoto, L
    Diamanti, E
    Dunaif, A
    Filicori, M
    Homburg, R
    Ibanez, L
    Laven, J
    Magoffin, D
    Nestler, J
    Norman, RJ
    Pasquali, R
    Pugeat, M
    Strauss, J
    Tan, S
    Taylor, A
    Wild, R
    Wild, S
    Ehrmann, D
    Lobo, R
    [J]. FERTILITY AND STERILITY, 2004, 81 (01) : 19 - 25
  • [9] The reproductive phenotype in polycystic ovary syndrome
    Chang, R. Jeffrey
    [J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (10): : 688 - 695
  • [10] Relationship of insulin receptor substrate-1 and-2 genotypes to phenotypic features of polycystic ovary syndrome
    Ehrmann, DA
    Tang, X
    Yoshiuchi, I
    Cox, NJ
    Bell, GI
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (09) : 4297 - 4300